Novartis Motion Is Wolf In Sheep's Clothing: Plaintiffs

Law360, New York (September 4, 2007, 12:00 AM EDT) -- Plaintiffs in the consolidated litigation over bone drugs Aredia and Zometa have slammed Novartis Pharmaceutical Corp.'s bid to break up their proposed classes as a veiled move for dismissal.

The suits, now consolidated in a Nashville district court, all accuse Novartis of strict liability and negligence in the production and distribution of the two drugs, which have been linked to osteonecrosis of the jaw, a condition involving painful deterioration of the jawbone.

In Wood v. Novartis, which concerned patients who had taken Aredia, and in Becker...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.